-+ 0.00%
-+ 0.00%
-+ 0.00%

GRI Bio Q3 EPS $(1.28) Misses $(0.93) Estimate

Benzinga·11/14/2025 14:28:49
Listen to the news
GRI Bio (NASDAQ:GRI) reported quarterly losses of $(1.28) per share which missed the analyst consensus estimate of $(0.93) by 37.63 percent. This is a 88.79 percent increase over losses of $(11.42) per share from the same period last year.